Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nyse  >  Bristol-Myers Squibb Co    BMY   US1101221083

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/29/2015 06/30/2015 07/01/2015 07/02/2015 07/06/2015 Date
65.97(c) 66.54(c) 67.67(c) 67.48(c) 67.58 Last
4 710 487 6 236 090 7 486 104 5 204 332 4 517 314 Volume
-2.32% +0.86% +1.70% -0.28% +0.15% Change
More quotes
Financials ($)
Sales 2015 15 364 M
EBIT 2015 3 291 M
Net income 2015 2 845 M
Finance 2015 1 761 M
Yield 2015 2,21%
Sales 2016 16 494 M
EBIT 2016 4 255 M
Net income 2016 3 779 M
Finance 2016 2 319 M
Yield 2016 2,32%
PER 2015 45,11
PER 2016 29,58
EV / Sales 2015 7,21x
EV / Sales 2016 6,68x
Capitalization 112 487 M
More Financials
Company
Bristol-Myers Squibb Co. is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products.Its pharmaceutical products include chemically-synthesized drugs or small molecules and an increasing portion of products produced from... 
Sector
Pharmaceuticals
Calendar
07/23Earnings Release
More about the company
Surperformance© ratings of Bristol-Myers Squibb Co
Trading Rating : Investor Rating :
More Ratings
Latest news on BRISTOL-MYERS SQUIBB CO
07/02 Celldex Therapeutics Appoints Richard Wright as Chief Commercial Officer
07/01 BRISTOL MYERS SQUIBB : Trademark Application for "I'M HERE" Filed by Bristol-Mye..
07/01 BRISTOL MYERS SQUIBB : Trademark Application for "APRIL" Filed by Bristol-Myers ..
07/01 BRISTOL MYERS SQUIBB : New Findings in Obesity Described from Bristol-Myers Squi..
07/01 BRISTOL MYERS SQUIBB : Study Results from Bristol-Myers Squibb Update Understand..
07/01 BRISTOL MYERS SQUIBB : European Commission Approves Bristol-Myers Squibb's Opdiv..
07/01 BRISTOL-MYERS SQUIBB CO : ex-dividend day
06/29 BRISTOL MYERS SQUIBB : Society for Immunotherapy of Cancer Reacts to EMA Approva..
More news
Sector news : Pharmaceuticals - NEC
12:56p TEVA PLANS TO RAISE MYLAN BID BY AS : Bloomberg
12:52pDJTeva May Raise Offer for Mylan to Range of $86 to $88 a Share -Bloomberg
11:31a JOHNSON & JOHNSON : Daratumumab Expanded Access Program Open to Eligible U.S. Pa..
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
10:08a ArQule's lead product candidate shows 52% disease control rate in certain col..
07/03 No Letting Up In Pharma As First-Half Gains Outweigh Losses
06/30 Deforestation Impacting Pharmaceutical Industry
06/26 PREMARKET BIOTECH DIGEST : Valent May Buy Zoetis, Medicines Co.'s Kengreal Appro..
06/26 IBM Will Not Have A Great Quarter - Cramer's Lightning Round (6/25/15)


Comments 
Advertisement
Chart BRISTOL-MYERS SQUIBB CO
Duration : Period :
Bristol-Myers Squibb Co Technical Analysis Chart | BMY | US1101221083 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions